Type 1 Diabetes (T1D) Clinical Trials in Boston, Massachusetts

4 studies are recruiting for type 1 diabetes (t1d) in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. App-Based Certified Diabetes Education Therapy (AB-CDE)

    The purpose of this study is to learn more about a smartphone application (app) called DailyDose, an investigational decision support tool that may help in managing your diabetes. DailyDose tracks your continuous glucose monitoring (CGM) data, insulin use, and exercise, and uses this information to…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Joslin Diabetes Center, Harvard School of Medicine, Boston, Massachusetts
    Locations
    6 in total
    Run by
    Oregon Health and Science University
  2. A Study of GNTI-122 in Adults Recently Diagnosed With T1D

    This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood cells in adult participants with recently diagnose…

    Stage
    Phase 1
    Ages
    18 to 55
    Site
    Joslin Diabetes Center, Boston, Massachusetts
    Locations
    10 in total
    Run by
    GentiBio, Inc
  3. Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

    The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to a…

    Stage
    Not phased
    Ages
    18 to 89
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Locations
    2 in total
    Run by
    University of Colorado, Denver
  4. Kidney Precision Medicine Project

    Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despite significant effort from industry and academia, development of pharmacologic therapies for AKI and …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Boston Medical Center, Boston, Massachusetts
    Locations
    13 in total
    Run by
    Icahn School of Medicine at Mount Sinai

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.